Get started
Author

M Favrot

Observed names: Favrot Mc, Favrot, Marie Christine, Favrot, Marie-Christine, M C FAVROT, M C Favrot, M C Favrot-Duvernois, M FAVROT, M-C Favrot, M. -C. Favrot, M. C. FAVROT, M. C. Favrot, M. FAVROT, M. Favrot, M.-C. Favrot, M.C Favrot, M.C. Favrot, M.Favrot, M.‐C. Favrot, MARIE C. FAVROT, MC Favrot, Marie C Favrot, Marie C. Favrot, Marie Favrot, Marie-Christine Favrot, Marie-christine Favrot, Marie‐C. Favrot, Marie‐Christine FAVROT, Marie‐Christine Favrot
Observed institutions: Centre National de la Recherche Scientifique, Royal Marsden NHS Foundation Trust, Inserm, Université Joseph Fourier, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Centre Hospitalier Universitaire de Grenoble, Centre Hospitalier Universitaire Vaudois, CEA Grenoble, Hôpital Cochin, Centre Léon Bérard, Ministère des Solidarités et de la Santé, Hôpital Nord, Hôpital Debrousse, Hôpital Edouard Herriot, Hôpital Louis Pradel, Centre Hospitalier Le Vinatier, Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail, Institut de Chimie Moléculaire de Grenoble, Institut pour l'avancée des biosciences, Hôpital de la Timone, Hôpital Albert Michallon, Canton of Geneva, Institut Curie
OpenAlex ID: A5111485813
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 · G M Brodeur, J Pritchard, et al. · Journal of Clinical Oncology · 2,285
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
1988 · G M Brodeur, R C Seeger, et al. · Journal of Clinical Oncology · 616
Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor
1998 · C. Menetrier-Caux, G. Montmain, et al. · Blood · 603
Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.
1994 · G M Brodeur, J Pritchard, et al. · PubMed · 392
Side‐effects of a systemic injection of linear polyethylenimine–DNA complexes
2001 · Patrice Chollet, Marie C. Favrot, et al. · The Journal of Gene Medicine · 377
PDF
Mesenchymal stem cells induce apoptosis of activated T cells
2005 · J Plumas, L Chaperot, et al. · Leukemia · 333
Human Bone Marrow Mesenchymal Stem Cells Can Express Insulin and Key Transcription Factors of the Endocrine Pancreas Developmental Pathway upon Genetic and/or Microenvironmental Manipulation In Vitro
2005 · Christine Moriscot, Florence de Fraipont, et al. · Stem Cells · 264
PDF
Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma
1997 · Jean-Yves Blay, Jean-François Rossi, et al. · International Journal of Cancer · 258
PDF
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor
1993 · JY Blay, N Burdin, et al. · Blood · 248
Review of mycotoxin‐detoxifying agents used as feed additives: mode of action, efficacy and feed/food safety
2009 · Caroline BOUDERGUE, Christine BUREL, et al. · EFSA Supporting Publications · 246
PDF
Template Assembled Cyclopeptides as Multimeric System for Integrin Targeting and Endocytosis
2004 · Didier Boturyn, Jean-Luc Coll, et al. · Journal of the American Chemical Society · 235
Consistent chromosomal translocation in alveolar rhabdomyosarcoma
1986 · Claude Turc-Carel, Sarab Lizard-Nacol, et al. · Cancer Genetics and Cytogenetics · 232
Oligoclonality of tumor-infiltrating lymphocytes from human melanomas.
1994 · I Puisieux, J Even, et al. · The Journal of Immunology · 221
In Vivo Delivery to Tumors of DNA Complexed with Linear Polyethylenimine
1999 · Jean-Luc Coll, Patrice Chollet, et al. · Human Gene Therapy · 203
Tumor-Specific Methylation in Saliva: A Promising Biomarker for Early Detection of Head and Neck Cancer Recurrence
2007 · Christian Adrien Righini, Florence de Fraipont, et al. · Clinical Cancer Research · 190
PDF
Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors.
1996 · N Voorzanger, R Touitou, et al. · PubMed · 190
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
1997 · H Rubie, O Hartmann, et al. · Journal of Clinical Oncology · 180
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification
2001 · D. Plantaz, J. Vandesompele, et al. · International Journal of Cancer · 130
PDF
New Multifunctional Molecular Conjugate Vector for Targeting, Imaging, and Therapy of Tumors
2005 · Elisabeth Garanger, Didier Boturyn, et al. · Molecular Therapy · 112
PDF
In vivo optical imaging of integrin αV-β3 in mice using multivalent or monovalent cRGD targeting vectors
2007 · Zhao-Hui Jin, Véronique Josserand, et al. · Molecular Cancer · 104
PDF
Inhibition of Apoptosis by Amphiregulin via an Insulin-like Growth Factor-1 Receptor-dependent Pathway in Non-small Cell Lung Cancer Cell Lines
2002 · Amandine Hurbin, Laurence Dubrez, et al. · Journal of Biological Chemistry · 104
An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS.
1985 · G Janossy, A J Pinching, et al. · PubMed Central · 103
Multivalent RGD synthetic peptides as potent α V β 3 integrin ligands
2006 · Elisabeth Garanger, Didier Boturyn, et al. · Organic & Biomolecular Chemistry · 99
Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factor.
1990 · J Y Blay, M C Favrot, et al. · PubMed · 88
Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.
1996 · V Combaret, N Gross, et al. · Journal of Clinical Oncology · 87
Works count: 264
Citation count: 11,860
H-index: 51
I10-index: 128
Year
Topic
Type